UVA-Induced MAPK Signaling

No Pathway Network information available for UVA-Induced MAPK Signaling

Pathways in the UVA-Induced MAPK Signaling SuperPath

#	Name	Source	Genes
1	UVA-Induced MAPK Signaling	QIAGEN	ATM BCL2L1 BID CASP3 CASP8 CASP9 CYCS EGFR FOS H3-3A H3-3B H3-4 H3C1 H3C10 H3C11 H3C12 H3C2 H3C3 H3C4 H3C6 H3C7 H3C8 HRAS JUN KRAS MAPK1 MAPK10 MAPK11 MAPK12 MAPK13 MAPK14 MAPK3 MAPK8 MAPK9 MRAS NRAS PARP1 PARP10 PARP11 PARP14 PARP15 PARP16 PARP3 PARP4 PARP8 PIK3R1 PIK3R2 PIK3R3 PIK3R4 PIK3R5 PLCB1 PLCB2 PLCB3 PLCB4 PLCD1 PLCD3 PLCD4 PLCE1 PLCG1 PLCG2 PLCZ1 PRKCA RPS6KA1 RPS6KA2 RPS6KA3 RPS6KA4 RPS6KA5 RPS6KA6 RPS6KB1 RRAS RRAS2 SMPD1 SMPD2 SMPD3 STAT1 TP53 (see all 76) (see less)
2	UVB-Induced MAPK Signaling	QIAGEN	AKT1 BAD EGFR EIF4E EIF4EBP1 EIF4EBP3 FOS H3-3A H3-3B H3-4 H3C1 H3C10 H3C11 H3C12 H3C2 H3C3 H3C4 H3C6 H3C7 H3C8 JUN MAP2K1 MAPK1 MAPK10 MAPK11 MAPK12 MAPK13 MAPK14 MAPK3 MAPK8 MAPK9 MTOR PIK3R1 PIK3R2 PIK3R3 PIK3R4 PIK3R5 PRKCA PRKCB PRKCD PRKCE PRKCG PRKCH PRKCI PRKCQ PRKCZ PRKD1 PRKD3 RPS6KA3 RPS6KA5 RPS6KB1 TP53 (see all 52) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	EGFR	Epidermal Growth Factor Receptor	Protein Coding	2
2	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	2
3	H3-3A	H3.3 Histone A	Protein Coding	2
4	H3-3B	H3.3 Histone B	Protein Coding	2
5	H3C1	H3 Clustered Histone 1	Protein Coding	2
6	H3C2	H3 Clustered Histone 2	Protein Coding	2
7	H3C3	H3 Clustered Histone 3	Protein Coding	2
8	H3C4	H3 Clustered Histone 4	Protein Coding	2
9	H3C6	H3 Clustered Histone 6	Protein Coding	2
10	H3C7	H3 Clustered Histone 7	Protein Coding	2
11	H3C8	H3 Clustered Histone 8	Protein Coding	2
12	H3C10	H3 Clustered Histone 10	Protein Coding	2
13	H3C11	H3 Clustered Histone 11	Protein Coding	2
14	H3C12	H3 Clustered Histone 12	Protein Coding	2
15	H3-4	H3.4 Histone, Cluster Member	Protein Coding	2
16	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	2
17	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	2
18	MAPK10	Mitogen-Activated Protein Kinase 10	Protein Coding	2
19	MAPK11	Mitogen-Activated Protein Kinase 11	Protein Coding	2
20	MAPK12	Mitogen-Activated Protein Kinase 12	Protein Coding	2
21	MAPK13	Mitogen-Activated Protein Kinase 13	Protein Coding	2
22	MAPK14	Mitogen-Activated Protein Kinase 14	Protein Coding	2
23	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	2
24	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	2
25	MAPK9	Mitogen-Activated Protein Kinase 9	Protein Coding	2
26	PIK3R5	Phosphoinositide-3-Kinase Regulatory Subunit 5	Protein Coding	2
27	PIK3R1	Phosphoinositide-3-Kinase Regulatory Subunit 1	Protein Coding	2
28	PIK3R2	Phosphoinositide-3-Kinase Regulatory Subunit 2	Protein Coding	2
29	PIK3R3	Phosphoinositide-3-Kinase Regulatory Subunit 3	Protein Coding	2
30	PIK3R4	Phosphoinositide-3-Kinase Regulatory Subunit 4	Protein Coding	2
31	PRKCA	Protein Kinase C Alpha	Protein Coding	2
32	RPS6KA3	Ribosomal Protein S6 Kinase A3	Protein Coding	2
33	RPS6KA5	Ribosomal Protein S6 Kinase A5	Protein Coding	2
34	RPS6KB1	Ribosomal Protein S6 Kinase B1	Protein Coding	2
35	TP53	Tumor Protein P53	Protein Coding	2
36	PARP1	Poly(ADP-Ribose) Polymerase 1	Protein Coding	1
37	PARP4	Poly(ADP-Ribose) Polymerase Family Member 4	Protein Coding	1
38	PARP3	Poly(ADP-Ribose) Polymerase Family Member 3	Protein Coding	1
39	ATM	ATM Serine/Threonine Kinase	Protein Coding	1
40	BCL2L1	BCL2 Like 1	Protein Coding	1
41	BID	BH3 Interacting Domain Death Agonist	Protein Coding	1
42	PARP11	Poly(ADP-Ribose) Polymerase Family Member 11	Protein Coding	1
43	CASP3	Caspase 3	Protein Coding	1
44	CASP8	Caspase 8	Protein Coding	1
45	CASP9	Caspase 9	Protein Coding	1
46	CYCS	Cytochrome C, Somatic	Protein Coding	1
47	PARP10	Poly(ADP-Ribose) Polymerase Family Member 10	Protein Coding	1
48	PARP16	Poly(ADP-Ribose) Polymerase Family Member 16	Protein Coding	1
49	PARP8	Poly(ADP-Ribose) Polymerase Family Member 8	Protein Coding	1
50	PARP15	Poly(ADP-Ribose) Polymerase Family Member 15	Protein Coding	1
51	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
52	PARP14	Poly(ADP-Ribose) Polymerase Family Member 14	Protein Coding	1
53	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	1
54	MRAS	Muscle RAS Oncogene Homolog	Protein Coding	1
55	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	1
56	PLCB1	Phospholipase C Beta 1	Protein Coding	1
57	PLCB2	Phospholipase C Beta 2	Protein Coding	1
58	PLCB3	Phospholipase C Beta 3	Protein Coding	1
59	PLCB4	Phospholipase C Beta 4	Protein Coding	1
60	PLCD1	Phospholipase C Delta 1	Protein Coding	1
61	PLCD3	Phospholipase C Delta 3	Protein Coding	1
62	PLCD4	Phospholipase C Delta 4	Protein Coding	1
63	PLCE1	Phospholipase C Epsilon 1	Protein Coding	1
64	PLCG1	Phospholipase C Gamma 1	Protein Coding	1
65	PLCG2	Phospholipase C Gamma 2	Protein Coding	1
66	PLCZ1	Phospholipase C Zeta 1	Protein Coding	1
67	RPS6KA1	Ribosomal Protein S6 Kinase A1	Protein Coding	1
68	RPS6KA2	Ribosomal Protein S6 Kinase A2	Protein Coding	1
69	RPS6KA4	Ribosomal Protein S6 Kinase A4	Protein Coding	1
70	RPS6KA6	Ribosomal Protein S6 Kinase A6	Protein Coding	1
71	RRAS	RAS Related	Protein Coding	1
72	RRAS2	RAS Related 2	Protein Coding	1
73	SMPD1	Sphingomyelin Phosphodiesterase 1	Protein Coding	1
74	SMPD2	Sphingomyelin Phosphodiesterase 2	Protein Coding	1
75	SMPD3	Sphingomyelin Phosphodiesterase 3	Protein Coding	1
76	STAT1	Signal Transducer And Activator Of Transcription 1	Protein Coding	1
77	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	1
78	BAD	BCL2 Associated Agonist Of Cell Death	Protein Coding	1
79	EIF4E	Eukaryotic Translation Initiation Factor 4E	Protein Coding	1
80	EIF4EBP1	Eukaryotic Translation Initiation Factor 4E Binding Protein 1	Protein Coding	1
81	EIF4EBP3	Eukaryotic Translation Initiation Factor 4E Binding Protein 3	Protein Coding	1
82	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	1
83	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	1
84	PRKCB	Protein Kinase C Beta	Protein Coding	1
85	PRKCD	Protein Kinase C Delta	Protein Coding	1
86	PRKCE	Protein Kinase C Epsilon	Protein Coding	1
87	PRKCG	Protein Kinase C Gamma	Protein Coding	1
88	PRKCH	Protein Kinase C Eta	Protein Coding	1
89	PRKCI	Protein Kinase C Iota	Protein Coding	1
90	PRKD1	Protein Kinase D1	Protein Coding	1
91	PRKD3	Protein Kinase D3	Protein Coding	1
92	PRKCQ	Protein Kinase C Theta	Protein Coding	1
93	PRKCZ	Protein Kinase C Zeta	Protein Coding	1

Disorders associated with UVA-Induced MAPK Signaling SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Noonan syndrome 1	Enrichment	HRAS, KRAS, MRAS, NRAS, RRAS, RRAS2	8.62
2	Rasopathy	Enrichment	HRAS, KRAS, MRAS, NRAS, RRAS2	6.54
3	Lung non-small cell carcinoma	Enrichment	EGFR, HRAS, KRAS, NRAS	6.54
4	Bladder cancer	Enrichment	ATM, EGFR, HRAS, KRAS, TP53	6.29
5	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS, KRAS, NRAS	6.17
6	Glioma susceptibility 1	Enrichment	H3-3A, H3C1, TP53	5.53
7	Nevus, epidermal	Enrichment	HRAS, KRAS, NRAS	5.24
8	Bryant-li-bhoj neurodevelopmental syndrome 2	Enrichment	H3-3A, H3-3B	4.84
9	Myeloma, multiple	Enrichment	ATM, H3C1, KRAS, PIK3R2, TP53	4.83
10	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS, NRAS	4.51
11	Juvenile myelomonocytic leukemia	Enrichment	KRAS, NRAS, RRAS	4.45
12	Lip and oral cavity carcinoma	Enrichment	EGFR, HRAS, TP53	4.45
13	Lung cancer susceptibility 3	Enrichment	EGFR, KRAS, TP53	4.23
14	Breast cancer	Enrichment	ATM, CASP8, JUN, KRAS, TP53	4.21
15	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS, KRAS, NRAS	4.14
16	Gliosarcoma	Enrichment	ATM, EGFR, TP53	4.05
17	Large congenital melanocytic nevus	Enrichment	HRAS, NRAS	4.03
18	Adenocarcinoma	Enrichment	ATM, TP53	4.03
19	Giant cell glioblastoma	Enrichment	ATM, EGFR, TP53	3.96
20	Lung sarcomatoid carcinoma	Enrichment	KRAS, TP53	3.73
21	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS, NRAS	3.73
22	Breast adenocarcinoma	Enrichment	AKT1, TP53	3.67
23	Ovarian cancer	Enrichment	ATM, EGFR, KRAS, RRAS2, TP53	3.60
24	Squamous cell carcinoma, head and neck	Enrichment	EGFR, TP53	3.52
25	Overgrowth syndrome	Enrichment	MTOR, PIK3R1	3.52
26	Pancreatic cancer	Enrichment	ATM, KRAS, TP53	3.45
27	Lung squamous cell carcinoma	Enrichment	EGFR, KRAS	3.34
28	Differentiated thyroid carcinoma	Enrichment	HRAS, KRAS, NRAS	3.25
29	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS, NRAS	3.19
30	Leukemia, chronic myeloid	Enrichment	KRAS, NRAS	3.19
31	Noonan syndrome 3	Enrichment	HRAS, KRAS	3.19
32	Gallbladder cancer	Enrichment	KRAS, TP53	3.19
33	Follicular thyroid carcinoma	Enrichment	HRAS, NRAS	3.19
34	Lung cancer	Enrichment	CASP8, EGFR, KRAS	3.13
35	Specific learning disability	Enrichment	MAPK1, RPS6KA3	3.11
36	Melanocytic nevus syndrome, congenital	Enrichment	HRAS, NRAS	3.07
37	Adult hepatocellular carcinoma	Enrichment	CASP8, TP53	2.96
38	Leukemia, chronic lymphocytic	Enrichment	ATM, TP53	2.87
39	Colorectal cancer	Enrichment	ATM, NRAS, PIK3R1, TP53	2.85
40	Leukemia, acute myeloid	Enrichment	KRAS, NRAS, TP53	2.84
41	Gastric cancer	Enrichment	ATM, KRAS, TP53	2.75
42	Hereditary breast carcinoma	Enrichment	ATM, KRAS, TP53	2.72
43	Rhabdomyosarcoma	Enrichment	HRAS, TP53	2.45
44	Hereditary breast ovarian cancer syndrome	Enrichment	ATM, KRAS, TP53	2.44
45	Proteus syndrome	Enrichment	AKT1	2.42
46	Coffin-lowry syndrome	Enrichment	RPS6KA3	2.42
47	Melorheostosis, isolated	Enrichment	MAP2K1	2.42
48	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.42
49	Ataxia-oculomotor apraxia 3	Enrichment	PIK3R5	2.42
50	Autoimmune lymphoproliferative syndrome, type iii	Enrichment	PRKCD	2.42
51	Noonan syndrome 13	Enrichment	MAPK1	2.42
52	Short syndrome	Enrichment	PIK3R1	2.42
53	Bone marrow failure syndrome 5	Enrichment	TP53	2.42
54	Papilloma of choroid plexus	Enrichment	TP53	2.42
55	Basal cell carcinoma 7	Enrichment	TP53	2.42
56	Autism 19	Enrichment	EIF4E	2.42
57	Intellectual developmental disorder, x-linked 19	Enrichment	RPS6KA3	2.42
58	Anaplastic thyroid carcinoma	Enrichment	TP53	2.42
59	Spinocerebellar ataxia 14	Enrichment	PRKCG	2.42
60	Melorheostosis	Enrichment	MAP2K1	2.42
61	Immunodeficiency 36 with lymphoproliferation	Enrichment	PIK3R1	2.42
62	Cowden syndrome 6	Enrichment	AKT1	2.42
63	Agammaglobulinemia 7, autosomal recessive	Enrichment	PIK3R1	2.42
64	Ductal carcinoma in situ	Enrichment	TP53	2.42
65	Congenital heart defects and ectodermal dysplasia	Enrichment	PRKD1	2.42
66	Bryant-li-bhoj neurodevelopmental syndrome 1	Enrichment	H3-3A	2.42
67	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.42
68	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.42
69	Symptomatic form of coffin-lowry syndrome in female carriers	Enrichment	RPS6KA3	2.42
70	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.42
71	Choroid plexus cancer	Enrichment	TP53	2.42
72	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.42
73	Malignant epithelial tumor of salivary glands	Enrichment	PRKD1	2.42
74	Arteriovenous malformations of the brain	Enrichment	EGFR, KRAS	2.30
75	Oculoectodermal syndrome	Enrichment	KRAS	2.25
76	Caspase 8 deficiency	Enrichment	CASP8	2.25
77	Nail disorder, nonsyndromic congenital, 3	Enrichment	PLCD1	2.25
78	Melanosis, neurocutaneous	Enrichment	NRAS	2.25
79	Noonan syndrome 6	Enrichment	NRAS	2.25
80	Noonan syndrome 11	Enrichment	MRAS	2.25
81	Spondylometaphyseal dysplasia with corneal dystrophy	Enrichment	PLCB3	2.25
82	Immune dysregulation, autoimmunity, and autoinflammation	Enrichment	PLCG1	2.25
83	Auriculocondylar syndrome 2a	Enrichment	PLCB4	2.25
84	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.25
85	Thrombocytopenia 4	Enrichment	CYCS	2.25
86	Immunodeficiency 31a	Enrichment	STAT1	2.25
87	Autoinflammation, antibody deficiency, and immune dysregulation	Enrichment	PLCG2	2.25
88	Endometrial serous adenocarcinoma	Enrichment	ATM	2.25
89	Immunodeficiency 31b	Enrichment	STAT1	2.25
90	Familial cold autoinflammatory syndrome 3	Enrichment	PLCG2	2.25
91	Acid sphingomyelinase deficiency	Enrichment	SMPD1	2.25
92	Auriculocondylar syndrome 2b	Enrichment	PLCB4	2.25
93	Congenital pulmonary airway malformation	Enrichment	KRAS	2.25
94	B-cell non-hodgkin lymphoma	Enrichment	ATM	2.25
95	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.25
96	Neurocutaneous melanocytosis	Enrichment	NRAS	2.25
97	Hepatocellular carcinoma	Enrichment	CASP8, TP53	2.18
98	Adrenocortical carcinoma, hereditary	Enrichment	TP53	2.12
99	Cervical cancer	Enrichment	TP53	2.12
100	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Enrichment	PIK3R5	2.12
101	Lymphoma, hodgkin, classic	Enrichment	TP53	2.12
102	Cebalid syndrome	Enrichment	MTOR	2.12
103	Congenital fibrosarcoma	Enrichment	TP53	2.12
104	Li-fraumeni syndrome 1	Enrichment	TP53	2.12
105	Sarcoma	Enrichment	TP53	2.12
106	Cervix carcinoma	Enrichment	TP53	2.12
107	Hodgkin's lymphoma	Enrichment	TP53	2.12
108	Smith-kingsmore syndrome	Enrichment	MTOR	2.12
109	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	2.12
110	Costello syndrome	Enrichment	HRAS	1.95
111	Encephalocraniocutaneous lipomatosis	Enrichment	KRAS	1.95
112	Spermatogenic failure 17	Enrichment	PLCZ1	1.95
113	Immunodeficiency 31c	Enrichment	STAT1	1.95
114	Cardiac valvular dysplasia, x-linked	Enrichment	ATM	1.95
115	Noonan syndrome 12	Enrichment	RRAS2	1.95
116	High grade glioma	Enrichment	ATM	1.95
117	Ocular melanoma	Enrichment	PLCB4	1.95
118	T-cell prolymphocytic leukemia	Enrichment	ATM	1.95
119	Wooly hair nevus	Enrichment	HRAS	1.95
120	Prostate cancer	Enrichment	ATM, TP53	1.94
121	Langerhans cell histiocytosis	Enrichment	MAP2K1	1.94
122	Osteogenic sarcoma	Enrichment	TP53	1.94
123	Nasopharyngeal carcinoma	Enrichment	TP53	1.94
124	Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi	Enrichment	PIK3R1	1.94
125	Neonatal nephrocutaneous inflammatory syndrome	Enrichment	EGFR	1.94
126	Immunodeficiency 14a with lymphoproliferation, autosomal dominant	Enrichment	PIK3R1	1.94
127	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.94
128	Anaplastic astrocytoma	Enrichment	TP53	1.94
129	Immunodeficiency 14	Enrichment	PIK3R1	1.94
130	Squamous cell carcinoma	Enrichment	TP53	1.94
131	Bone osteosarcoma	Enrichment	TP53	1.94
132	Neonatal inflammatory skin and bowel disease	Enrichment	EGFR	1.94
133	Non-immune hydrops fetalis	Enrichment	HRAS, KRAS	1.89
134	Cardiofaciocutaneous syndrome 1	Enrichment	MAP2K1	1.82
135	Small cell cancer of the lung	Enrichment	TP53	1.82
136	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.82
137	Megalencephaly-capillary malformation-polymicrogyria syndrome	Enrichment	PIK3R2	1.82
138	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.82
139	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Enrichment	PIK3R2	1.82
140	Focal cortical dysplasia, type ii	Enrichment	MTOR	1.82
141	Congenital generalized lipodystrophy	Enrichment	FOS	1.82
142	Cardiofaciocutaneous syndrome	Enrichment	MAP2K1	1.82
143	Hereditary ataxia	Enrichment	PRKCG	1.82
144	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.82
145	Isolated focal cortical dysplasia type ii	Enrichment	MTOR	1.82
146	Ataxia-telangiectasia	Enrichment	ATM	1.78
147	Polycythemia vera	Enrichment	ATM	1.78
148	Niemann-pick disease, type a	Enrichment	SMPD1	1.78
149	Niemann-pick disease, type b	Enrichment	SMPD1	1.78
150	Nephrotic syndrome, type 3	Enrichment	PLCE1	1.78
151	Ceroid lipofuscinosis, neuronal, 6a	Enrichment	SMPD1	1.78
152	Koolen-de vries syndrome	Enrichment	ATM	1.78
153	Spermatocytoma	Enrichment	HRAS	1.78
154	Rhabdomyosarcoma 2	Enrichment	TP53	1.72
155	Lymphoma	Enrichment	TP53	1.72
156	Histiocytoid hemangioma	Enrichment	FOS	1.72
157	Acute megakaryocytic leukemia	Enrichment	TP53	1.72
158	Hemimegalencephaly	Enrichment	MTOR	1.72
159	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	1.65
160	Auriculocondylar syndrome 1	Enrichment	PLCB4	1.65
161	Developmental and epileptic encephalopathy 12	Enrichment	PLCB1	1.65
162	Mantle cell lymphoma	Enrichment	ATM	1.65
163	Pilocytic astrocytoma	Enrichment	KRAS	1.65
164	Epidermolytic nevus	Enrichment	HRAS	1.65
165	Oculomotor apraxia	Enrichment	ATM	1.65
166	Li-fraumeni syndrome	Enrichment	TP53	1.64
167	Cowden syndrome 1	Enrichment	EGFR	1.64
168	Adrenocortical carcinoma	Enrichment	TP53	1.64
169	Esophageal cancer	Enrichment	TP53	1.58
170	Capillary malformation-arteriovenous malformation 1	Enrichment	MAP2K1	1.58
171	Renal cell carcinoma, papillary, 1	Enrichment	MTOR	1.58
172	Essential thrombocythemia	Enrichment	TP53	1.58
173	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	1.58
174	Niemann-pick disease, type c1	Enrichment	SMPD1	1.56
175	Glioblastoma	Enrichment	ATM	1.56
176	Niemann-pick disease	Enrichment	SMPD1	1.56
177	Autosomal thrombocytopenia with normal platelets	Enrichment	CYCS	1.56
178	Gastroesophageal reflux	Enrichment	RPS6KA3	1.52
179	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.52
180	Orthostatic intolerance	Enrichment	RPS6KA3	1.52
181	Lennox-gastaut syndrome	Enrichment	MAPK10	1.52
182	Melanoma, uveal	Enrichment	PLCB4	1.48
183	Clear cell renal cell carcinoma	Enrichment	ATM	1.48
184	Chronic mucocutaneous candidiasis	Enrichment	STAT1	1.48
185	Inflammatory bowel disease 1	Enrichment	PRKCQ	1.47
186	Arteriovenous malformation	Enrichment	MAP2K1	1.47
187	Primary hyperaldosteronism	Enrichment	TP53	1.47
188	Ventricular septal defect	Enrichment	RPS6KA3	1.47
189	Cowden syndrome	Enrichment	AKT1	1.47
190	Stroke, ischemic	Enrichment	PRKCH	1.42
191	Myopathy, x-linked, with excessive autophagy	Enrichment	MAP2K1	1.42
192	Familial colorectal cancer	Enrichment	TP53	1.42
193	Autosomal non-syndromic agammaglobulinemia	Enrichment	PIK3R1	1.42
194	Inherited cancer-predisposing syndrome	Enrichment	ATM, EGFR, TP53	1.42
195	Pilomyxoid astrocytoma	Enrichment	KRAS	1.41
196	Myelodysplastic syndrome	Enrichment	TP53	1.38
197	Meningioma	Enrichment	AKT1	1.35
198	Chromosome 1p36 deletion syndrome	Enrichment	PRKCZ	1.31
199	Nephrotic syndrome, type 1	Enrichment	PLCE1	1.31
200	Developmental and epileptic encephalopathy 14	Enrichment	PLCB1	1.31
201	Colonic benign neoplasm	Enrichment	ATM	1.31
202	Lynch syndrome 1	Enrichment	ATM	1.26
203	Renal cell carcinoma, nonpapillary	Enrichment	MTOR	1.25
204	Rare genetic intellectual disability	Enrichment	MTOR	1.25
205	Immune deficiency disease	Enrichment	ATM	1.22
206	Uterine corpus cancer	Enrichment	ATM	1.22
207	Familial colorectal cancer type x	Enrichment	ATM	1.22
208	Heart, malformation of	Enrichment	MAPK1	1.17
209	Diffuse large b-cell lymphoma	Enrichment	TP53	1.15
210	Breast-ovarian cancer, familial 1	Enrichment	ATM	1.15
211	Protein-deficiency anemia	Enrichment	NRAS	1.15
212	Hepatoblastoma	Enrichment	TP53	1.11
213	Lynch syndrome	Enrichment	KRAS	1.09
214	Diamond-blackfan anemia 1	Enrichment	TP53	1.07
215	Focal segmental glomerulosclerosis	Enrichment	PLCE1	0.97
216	Endometrial cancer	Enrichment	ATM	0.95
217	Non-syndromic x-linked intellectual disability	Enrichment	RPS6KA3	0.89
218	Diamond-blackfan anemia	Enrichment	TP53	0.89
219	Hydrops fetalis, nonimmune	Enrichment	HRAS	0.87
220	Genetic steroid-resistant nephrotic syndrome	Enrichment	PLCE1	0.76
221	Hypertelorism	Enrichment	RPS6KA3	0.74
222	Benign epilepsy with centrotemporal spikes	Enrichment	PLCB1	0.69
223	Centralopathic epilepsy	Enrichment	PLCB1	0.67
224	Nephrotic syndrome	Enrichment	PLCE1	0.67
225	West syndrome	Enrichment	PLCB1	0.66
226	Thrombocytopenia	Enrichment	CYCS	0.63
227	Autism spectrum disorder	Enrichment	MAP2K1	0.46
228	Microcephaly	Enrichment	MAPK1	0.42

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

UVA-Induced MAPK Signaling

Pathway Network for UVA-Induced MAPK Signaling

Member Pathways for UVA-Induced MAPK Signaling

Pathways in the UVA-Induced MAPK Signaling SuperPath

Associated Genes for UVA-Induced MAPK Signaling

Associated Disorders for UVA-Induced MAPK Signaling

Disorders associated with UVA-Induced MAPK Signaling SuperPath

STRING Interaction Network for UVA-Induced MAPK Signaling

Sources for UVA-Induced MAPK Signaling